Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bifonazole versus clotrimazole for pityriasis versicolor
IRCT20241028063523N1Phase 4Completed
- Sponsor
- PNS Shifa
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bifonazole and clotrimazole in pityriasis versicolor, sponsored by PNS Shifa. Primary endpoint: Efficacy with clinical and mycological cure. Started Nov 2024; status: completed.
02
Drugs
bifonazoleclotrimazole
03
Conditions
pityriasis versicolor
Beyond the preview
Go deeper on IRCT20241028063523N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241028063523N1.